Cell Therapy Will Transform Medicine as We Know It, Says Jason Bock, CTMC
May 16, 2024•6 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
This is a free preview of a paid episode. To hear more, visit www.mendelspod.com
Today, we pursue an exciting area of medicine for the first time: cell therapy for solid tumors.Most, if not all, of our audience will be familiar with the success of CAR-T therapies for blood cancers. But only 10% of cancer is in the blood. The other 90% develop solid tumors. Jason Bock is the CEO and founder of CTMC, a new company aiming to speed the advancement of the entire field of cell therapies. First, we cover this new treatment for solid tumors and discuss the near-science-fiction action of tumor-infiltrating lymphocytes (til).
For the best experience, listen in Metacast app for iOS or Android